177 related articles for article (PubMed ID: 37980213)
1. Extrahepatic manifestations of HCV where do we stand?
Mokhles MA
Med Clin (Barc); 2024 Mar; 162(5):231-237. PubMed ID: 37980213
[TBL] [Abstract][Full Text] [Related]
2. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
Rutledge SM; Chung RT; Sise ME
Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic manifestations in chronic hepatitis C virus carriers.
Rosenthal E; Cacoub P
Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
[TBL] [Abstract][Full Text] [Related]
5. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
6. Renal Manifestations of Hepatitis C Virus.
Ferri C; Giuggioli D; Colaci M
Clin Liver Dis; 2017 Aug; 21(3):487-497. PubMed ID: 28689588
[TBL] [Abstract][Full Text] [Related]
7. Extrahepatic morbidity and mortality of chronic hepatitis C.
Negro F; Forton D; Craxì A; Sulkowski MS; Feld JJ; Manns MP
Gastroenterology; 2015 Nov; 149(6):1345-60. PubMed ID: 26319013
[TBL] [Abstract][Full Text] [Related]
8. The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Muro K; Toda N; Yamamoto S; Yanagita M
Intern Med; 2021 Feb; 60(4):583-589. PubMed ID: 32999232
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
[TBL] [Abstract][Full Text] [Related]
10. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
11. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Extrahepatic Manifestations of Hepatitis C Virus.
Degasperi E; Aghemo A; Colombo M
Clin Liver Dis; 2017 Aug; 21(3):631-643. PubMed ID: 28689598
[TBL] [Abstract][Full Text] [Related]
13. Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.
Honma Y; Shibata M; Morino K; Koya Y; Hayashi T; Ogino N; Kusanaga M; Oe S; Miyagawa K; Abe S; Tabaru A; Harada M
Dig Dis Sci; 2023 Feb; 68(2):685-698. PubMed ID: 36100828
[TBL] [Abstract][Full Text] [Related]
14. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review.
Obrișcă B; Jurubiță R; Sorohan B; Iliescu L; Baston C; Bobeică R; Andronesi A; Leca N; Ismail G
Clin Rheumatol; 2019 Dec; 38(12):3677-3687. PubMed ID: 31172367
[TBL] [Abstract][Full Text] [Related]
16. Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome.
Zignego AL; Marri S; Gragnani L
Minerva Gastroenterol (Torino); 2021 Sep; 67(3):218-226. PubMed ID: 33793154
[TBL] [Abstract][Full Text] [Related]
17. Clinico-immunological outcomes of HCV-cured cryoglobulinemia: Lower relapse rate with interferon-based than interferon-free therapy.
Colantuono S; Marrapodi R; Del Padre M; Collalti G; Garzi G; De Santis A; Fiorilli M; Basili S; Visentini M; Casato M
Liver Int; 2021 Jan; 41(1):70-75. PubMed ID: 33064930
[TBL] [Abstract][Full Text] [Related]
18. Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis.
Conca P; Cafaro G; De Renzo A; Coppola A; Cimino E; Tarantino G
Int J Mol Sci; 2015 Jun; 16(6):14075-85. PubMed ID: 26101866
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy.
Mazzaro C; Dal Maso L; Mauro E; Visentini M; Tonizzo M; Gattei V; Andreone P; Pozzato G
Autoimmun Rev; 2020 Aug; 19(8):102589. PubMed ID: 32540448
[TBL] [Abstract][Full Text] [Related]
20. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
